NCT07305519 The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
| NCT ID | NCT07305519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Roma La Sapienza |
| Condition | Preterm Labor |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).
Eligibility Criteria
Inclusion Criteria: * Signed informed consent Singleton pregnancy Maternal age ≥ 18 years Gestational age between 20+0 and 34+0 weeks at enrollment Cervical length between 15 mm and 30 mm measured by transvaginal ultrasound Exclusion Criteria: * Fetal structural anomalies Maternal chronic diseases or pregnancy-related conditions, including diabetes, hypertension, preeclampsia, cardiovascular disease, infections, or autoimmune disorders Multiple gestation Fetal growth abnormalities (estimated fetal weight \<10th or \>90th percentile) Prelabor rupture of membranes (PROM)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07305519 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Preterm Labor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305519 currently recruiting?
Yes, NCT07305519 is actively recruiting participants. Contact the research team at giuseppe.rizzo@uniroma1.it for enrollment information.
Where is the NCT07305519 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT07305519 clinical trial?
NCT07305519 is sponsored by University of Roma La Sapienza. The trial plans to enroll 150 participants.